Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.
About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
Response to natural SARS-CoV-2 infection suggests HIV-positive people can also respond well to COVID-19 vaccines.
People with immune deficiency may not respond as well to vaccines but could still gain some protection.
Research suggests protective effect of natural infection or vaccination is likely to be persistent.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Long-lived memory immune cells continue to provide protection even after antibody levels drop.
Screening patients for autoantibodies against interferons could help predict which patients are more likely to become very sick.
Existing T cells may help account for the wide range COVID-19 symptoms.
Antibody analysis may provide guidance for developing vaccines and antibodies as treatments for COVID-19.
Both HIV and autoimmune clinicians reporting lower than expected incidence
Th1-Th2 “shift” rears its ugly head
“Young researchers such as myself…can provide a new perspective and contribute to the conversation for a cure,” says Chidera Ejikeme.
Over $12 million in grants has been awarded to the Wistar Institute to research the links between opioid receptors and immune activation.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.